ACTO

ACTO is a life sciences software company that develops an AI-powered Intelligent Field Excellence (IFE) platform designed to support commercial, medical, and launch teams at biopharmaceutical and medical device companies. The platform combines training, coaching, practice, and AI-driven workflow tools to help field professionals — including sales representatives and Medical Science Liaisons (MSLs) — remain competent and confident in face-to-face interactions with healthcare professionals (HCPs). Founded in 2014 by Parth Khanna, Kapil Kalra, and Kumar Erramilli, ACTO is headquartered in Canada and serves over 50,000 field professionals across more than 330 product launches and 2,600 drugs, devices, and therapies.

The platform is organized around three functional pillars — Educate, Engage, and Augment — each addressing a distinct aspect of field team readiness. ACTO serves roles across sales and commercial excellence, marketing and brand, medical affairs, and commercial learning and development (CL&D), with use cases spanning product launches, new hire onboarding, sales meetings, and field team compliance.

Educate: Training and Learning Modules

• Training: Converts complex clinical content into bite-sized, action-oriented learning modules intended to boost engagement and improve certification rates among sales reps and MSLs.
• Gamification: Incorporates game mechanics into home study, live training sessions, and post-event follow-through to reinforce concepts, build confidence, and improve knowledge retention.
• Insights: Tracks learning progress and continuous improvement, and links training outcomes to field performance and business results.
• Adaptive Learning: Delivers reinforcement training tailored to each field professional's experience level and learning needs, designed to address knowledge decay over time.

Engage: Field Team Enablement

• AI Roleplay (CxZone): Provides field professionals with an AI-simulated practice environment that is accessible on demand and delivers immediate feedback. This module won two 2025 Pharmaceutical Technology Excellence Awards, for Innovation and for Product Launches in the Field Simulation category.
• Coaching: Supports skill development and manager connection through both live and asynchronous coaching tools.
• Field Meetings: Consolidates pre-event, live, and post-event training, content, and support into a single application, with gamification elements to increase engagement.
• Messaging: Allows field teams to personalize HCP presentations using approved content, with the ability to share materials and track HCP engagement.

Augment: AI Agents and Workflow Automation

• Workflow Agents: Automates tasks and processes within the ACTO platform using AI agents, moving field teams from task management toward higher-impact activities.
• AI SuperAgents: Role-based AI agents purpose-built for life sciences field teams, announced in 2025. These agents are designed to orchestrate work across specific roles, with early adopters reporting significant reductions in time spent retrieving information and improvements in time-to-field readiness, productivity, and HCP interaction confidence.

Company History and Funding

• Founded on July 21, 2014, initially as an industry-agnostic learning solution built on microlearning and action-based learning principles.
• Gained early traction in life sciences and formally focused on the sector in 2017 following engagement with a cohort of life sciences leaders.
• Secured seed funding in 2018 from MaRS IAF, Extreme Venture Partners, and Panache Ventures.
• Raised US$11.5 million in Series A funding in 2020, led by Resolve Growth Partners, and acquired Scrimmage and CoHealth in the same year.
• Raised US$18 million in Series B financing in 2022, led by Questa Capital.
• Acquired 4th Down Solutions in 2024, expanding its presence among top 50 pharmaceutical companies.

Partnerships, Integrations, and Recognition

• ACTO holds both AI Partner and Silver Product Partner status with Veeva, and has been recognized as a top Veeva AI solutions provider by Pharma Tech Outlook.
• Recognized as a Major Contender in Everest Group's Life Sciences Next-generation Customer Engagement Platforms (CEP) PEAK Matrix® Assessment in both 2023 and 2024.
• Additional recognition includes PM360 Innovator (2024), multiple Brandon Hall awards for excellence in technology and learning, LTEN Excellence Awards, and repeated Great Place to Work certification in Canada from 2020 through 2024.
• Customers include Currax Pharmaceuticals, with endorsements from industry figures including a former President of J&J Vision.

ACTO serves pharma, biotech, and medical device companies of varying sizes, with a stated mission of helping these organizations improve patient outcomes as they bring therapies to market. The company maintains a worldwide presence and a partner ecosystem designed to extend the value of its platform alongside complementary solutions.